Savient Pharmaceuticals (SVNT) Reports Q3 Loss of $0.23
More News related to SVNT
- Savient Pharmaceuticals (SVNT) Reports Q3 Loss of $0.23
- Savient Pharmaceuticals Reports Third Quarter 2009 Financial Results
- Trading Radar for 11/04: Cisco (CSCO), Comcast (CMCSA), Tyco (TEL), Molson Coors (TAP) Report
- Savient Pharmaceuticals to Hold Third Quarter 2009 Financial Results Conference Call on Thursday, November 5, 2009
- Savient Pharmaceuticals to Present at the Oppenheimer 20th Annual Healthcare Conference
More News related to Earnings
- Highlights From SJM's Q2 Conference Call: Acquisition of Folger's Really Paying Off; Comfortable Raising FY Outlook
- Highlights From INTU's Q1 Conference Call: Issues Mixed Guidance for Q2, In-line for FY10
- Highlights From The GAP's (GPS) Q3 Conference Call: Total Comp-Store Sales Were Flat Vs. Down 12% Last Year
- Highlights From DELL's Q3 Conference Call: Revenues Adversely Affected By Timing of Windows 7 Launch
- D. R. Horton (DHI) Home Orders Rise, But Losses Continue
Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) reports Q3 loss of $0.23, 7 cents better than the analyst estimate of $0.30. Revenue for the quarter was $0.3 million, which compares to the estimate of $0.6 million.
Related Categories
EarningsStocks Mentioned
-0.19Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
